SCHEMBL7916437

SCHEMBL7916437

CCCOc1c(C#N)c(-n2ncnn2)nc2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ TP53 P04637 2/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ MAPT P10636 3/20 0.34
▸ TOP2A P11388 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ APAF1 O14727 1/20 0.32
▸ CASP3 P42574 1/20 0.32
▸ CASP6 P55212 1/20 0.32
▸ SENP8 Q96LD8 1/20 0.32
▸ SENP7 Q9BQF6 1/20 0.32
▸ SENP6 Q9GZR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2871462 0.87 ALDH1A1 (0.40) ALDH1A1KDM4ETP53NPC1RAB9A
SCHEMBL7914416 0.81 ALDH1A1 (0.40) ALDH1A1KDM4ETP53NPC1RAB9A
SCHEMBL7913463 0.81 ALDH1A1 (0.37) ALDH1A1KDM4ETP53NPC1RAB9A
SCHEMBL7914406 0.81 CYP1A2 (0.38) ALDH1A1KDM4ETP53NPC1RAB9A
SCHEMBL7916401 0.81 ADORA2A (0.43) ALDH1A1KDM4ETP53NPC1RAB9A
SCHEMBL7916445 0.80 ALDH1A1 (0.40) ALDH1A1KDM4ETP53MAPTTOP2A
SCHEMBL7906142 0.78 KDM4E (0.42) ALDH1A1KDM4ERAB9AMAPTPDE10A
SCHEMBL20975373 0.77 KDM4E (0.46) ALDH1A1KDM4ETP53NPC1RAB9A
SCHEMBL12495116 0.72 HTR2C (0.39) ALDH1A1KDM4ETP53NPC1RAB9A
SCHEMBL7913445 0.72 KDM4E (0.41) ALDH1A1KDM4ETP53MAPTTOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6297258-B1 USEFUL AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE. AMERICAN CYANAMID COMPANY 2001-10-02 — — US disclosed
Send feedback